Literature DB >> 22361741

Pressure overload leads to an increase of cardiac resident stem cells.

Stefan Rupp1, Jürgen Bauer, Susanne von Gerlach, Stephan Fichtlscherer, Andreas M Zeiher, Stefanie Dimmeler, Dietmar Schranz.   

Abstract

Recent studies suggest that the mammalian heart possesses some capacity for cardiac regeneration. This regenerative capacity is primarily documented postnatally and after myocardial infarction or pressure overload. Although the cell type that mediates endogenous regeneration is unclear, cardiac stem cells might be considered as potential candidates. To determine the number of c-kit + cardiac resident cells under conditions of pressure overload, we evaluated specimens derived from n = 8 patients with pressure overloaded single right ventricles in comparison to n = 4 explanted hearts from patients with dilated cardiomyopathy and n = 14 biopsies from children after heart transplantation. The age of the patients ranged from 16 days to 19 years. For quantification of cardiac stem cells, c-kit+/mast cell tryptase-/CD45- cells were counted and expressed as percent of the total nuclei. In specimens from patients with dilated cardiomyopathy, 0.13 ± 0.09% c-kit +/mast cell tryptase-/CD45- cells were detected. However, in specimens from patients with pressure overloaded single right ventricles, the numbers of c-kit+/mast cell tryptase-/CD45- cells were significantly higher (0.41 ±0.24%, p < 0.05). Under conditions of pressure overload, the right ventricle shows an approximately three-fold increase in c-kit+/mast cell tryptase-/CD45- cardiac resident cells. Despite the fact that this increased number of c-kit+ cells is not sufficient to prevent the failing heart from congestive heart failure, understanding the mechanism that leads to an increase of presumably cardiac resident stem cells under conditions of pressure overload might help to develop new strategies to enhance endogenous repair.

Entities:  

Mesh:

Year:  2012        PMID: 22361741     DOI: 10.1007/s00395-012-0252-x

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  11 in total

Review 1.  Cardiac regeneration in children.

Authors:  Stefan Rupp; Dietmar Schranz
Journal:  Pediatr Cardiol       Date:  2015-01-30       Impact factor: 1.655

2.  Pediatric End-Stage Failing Hearts Demonstrate Increased Cardiac Stem Cells.

Authors:  Brody Wehman; Sudhish Sharma; Rachana Mishra; Yin Guo; Evan J Colletti; Zachary N Kon; Srinivasa Raju Datla; Osama T Siddiqui; Keerti Balachandran; Sunjay Kaushal
Journal:  Ann Thorac Surg       Date:  2015-06-30       Impact factor: 4.330

3.  Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy.

Authors:  Muzammil Mushtaq; Darcy L DiFede; Samuel Golpanian; Aisha Khan; Samirah A Gomes; Adam Mendizabal; Alan W Heldman; Joshua M Hare
Journal:  J Cardiovasc Transl Res       Date:  2014-10-30       Impact factor: 4.132

4.  Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair.

Authors:  Ke Cheng; Konstantinos Malliaras; Rachel Ruckdeschel Smith; Deliang Shen; Baiming Sun; Agnieszka Blusztajn; Yucai Xie; Ahmed Ibrahim; Mohammad Amin Aminzadeh; Weixin Liu; Tao-Sheng Li; Michele A De Robertis; Linda Marbán; Lawrence S C Czer; Alfredo Trento; Eduardo Marbán
Journal:  JACC Heart Fail       Date:  2014-02       Impact factor: 12.035

5.  Stromal cell derived factor-1α promotes C-Kit+ cardiac stem/progenitor cell quiescence through casein kinase 1α and GSK3β.

Authors:  Neviana Dimova; Marcin Wysoczynski; Gregg Rokosh
Journal:  Stem Cells       Date:  2014-02       Impact factor: 6.277

Review 6.  Stem cell therapy and tissue engineering for correction of congenital heart disease.

Authors:  Elisa Avolio; Massimo Caputo; Paolo Madeddu
Journal:  Front Cell Dev Biol       Date:  2015-06-30

Review 7.  Stem Cell Therapy and Congenital Heart Disease.

Authors:  Timothy J Nelson; Susana Cantero Peral
Journal:  J Cardiovasc Dev Dis       Date:  2016-07-05

Review 8.  Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity.

Authors:  Donato Cappetta; Antonella De Angelis; Luigi Sapio; Lucia Prezioso; Michela Illiano; Federico Quaini; Francesco Rossi; Liberato Berrino; Silvio Naviglio; Konrad Urbanek
Journal:  Oxid Med Cell Longev       Date:  2017-10-18       Impact factor: 6.543

Review 9.  Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives.

Authors:  Maria E Marketou; Fragiskos Parthenakis; Panos E Vardas
Journal:  Stem Cells Int       Date:  2015-12-20       Impact factor: 5.443

10.  Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy.

Authors:  Marie Gerisch; Jan Smettan; Sabine Ebert; Maria Athelogou; Beate Brand-Saberi; Nick Spindler; Wolf C Mueller; Shibashish Giri; Augustinus Bader
Journal:  Front Genet       Date:  2018-03-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.